ConductScience.org, home

Library / Trial comparisons

Home Assessment and Initiation of ART vs Clinic-based ART Assessment and Initiation: Uptake of Home-based HIV Testing

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 10.6450.6350.656wilsonClinicalTrials.gov
Risk in group 20.5240.5130.534wilsonClinicalTrials.gov
Risk difference, group 1 minus group 20.1220.1070.136newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 21.231.21.26logClinicalTrials.gov
Odds ratio, group 1 over group 21.651.551.76logClinicalTrials.gov
Number needed to treat, for one more participant with the outcome on Home Assessment and Initiation of ART than on Clinic-based ART Assessment and Initiation8.227.339.37from the risk difference intervalClinicalTrials.gov

Groups 2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1Home Assessment and Initiation of ARTOptional home initiation of HIV care following HIV self-testing5,2878,194OG000ClinicalTrials.gov
Group 2Clinic-based ART Assessment and InitiationFacility-based HIV care following HIV self-testing only4,4338,466OG001ClinicalTrials.gov

Outcome 5

FieldValueSource
TypeSECONDARYClinicalTrials.gov
TitleUptake of Home-based HIV TestingClinicalTrials.gov
Description
Comparison between study arms of the proportion of all resident adults who request HIV testing (either as standard HTC or as supervised HIV self-testing) from the resident community counsellor during the first year of the study.
ClinicalTrials.gov
Time frameThe first 6-months following home assessment and initiation of ART being made availableClinicalTrials.gov
PopulationClinicalTrials.gov

Trial 8

FieldValueSource
TitleHome Assessment and Initiation of Antiretroviral Therapy for HIV in MalawiClinicalTrials.gov
NCT numberNCT01414413ClinicalTrials.gov
PhasesNAClinicalTrials.gov
ConditionsHIVClinicalTrials.gov
InterventionsHome assessment and initiation of ART, Clinic-based ART assessment and initiationClinicalTrials.gov
Lead sponsorLiverpool School of Tropical MedicineClinicalTrials.gov
Results first posted2014-04-07ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT01414413?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.